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Abstract: 
Background: Cervical cancer is one of the leading 
causes of mortality and morbidity in women 
worldwide. This can be detected effectively in pre 
invasive forms by using certain screening tests 
among which the Pap smear test is most widely 
used. This study was conducted to determine the 
frequency of abnormal cervical cytology by Pap 
smear and to stress upon the role of Pap smear in 
screening of cervical cancer. 
Materials & Methods: A cross sectional 
descriptive study was carried out on 121 patients, 
reporting to a private lab, selected through non 
probability convenience sampling technique. 
Patients with complete referral forms were included 
and then their lab reports were reviewed. The 
required data (including slide number, age, reason 
of referral and lab findings) was collected on a 
Proforma and was further analyzed by SPSS version 
23. By using descriptive statistics, frequencies were 
calculated and cross tabulations were made. 
Results: Out of 121 lab reports, 57%(n=69) were 
normal, 34.7%(n=42) had inflammation without 
atypia, 1.7%(n=2) had Inflammation with atypia, 
2.5%(n=3) had ASCUS, 1.7%(n=2) had LSIL, 
1.7%(n=2) had HSIL and 0.8%(n=1) had cervical 
cancer. On total, 
8.4%(n=10) reports were having abnormal cervical 
cytologies including one case (0.8%) of Invasive 
cervical carcinoma. 7.6% cases were found to be 
potentially pre invasive (i.e. Atypia , ASCUS , LSIL , 
HSIL). Out of which 66% were found in the age 
group of above 40 years. 
Conclusion: Pap test effectively picked up 7.6% 
cases of abnormal cervical epithelium in potentially 
pre invasive forms. 66% of these cases were found in 
the age group of above 40 years. 
Key words: Cervical cancer, Pap smear test, 
screening test 
Introduction: 
Worldwide, cervical cancer is rated as the third most 
frequent cancer in women and seventh most frequent 
cancer in general population with high morbidity and 
mortality rates.1 In the year 2012, 527,624 new cases 
and 265,672 deaths were recorded all over the world. 
In Pakistan, it ranks as third leading cause of cancer in 
women with annual 5,233 new cases and 2,876 deaths.2 
It progresses very slowly in about 10-15 years from 
pre-invasive to invasive form.1,3 Pre-invasive forms 
can be effectively detected beforehand by using 
appropriate laboratory tests.3 No other cancer can be 
screened out and cured so effectively as does the 
cervical cancer.1 Cervical cancer screening can be done 
via two tests; Cytology based pap smear test and HPV 
testing.4 Pap test is the most commonly applied 
screening test to identify pre-invasive forms and thus 
contributing in reducing the incidence of cervical 
carcinoma and mortality caused by it.5 
People in Pakistan have got very scarce knowledge 
regarding these screening tests. Moreover, these 
facilities are not available in all parts of the country. 
Cervical cancer screening coverage is just 2.3 %.2 As 
per a KAP survey conducted in Lahore, only 5% of 
females were found to be aware of screening and 
among them 2.6% had a screening test done once in 
life. Routine Pap test is not practiced in gynecological 
clinics and hospitals.6,7 
This study is aimed to determine the frequency of 
abnormal cervical cytology by Pap smear and to stress 
upon the role of Pap smear test in screening of cervical 
cancers. Moreover, results of this research will be 
helpful at the level of policy making too. 
 
 
Materials and Methods: 
This cross sectional descriptive study was done in a 
private laboratory of Rawalpindi to analyze the 
previously conducted cervical Pap smears during the 
period of 2008-2017. After excluding the referral forms 
with inadequate data, 121 patients were selected on 
the basis of non-probability convenience sampling and 
their laboratory reports were reviewed. Information 
regarding slide no., age, reason of referral and 
laboratory findings were recorded on a proforma. 
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Reports of conventional Pap test were considered. The 
Lab reports were classified by the pathologist using 
The Bethesda System 2001 of classification for cervical 
cytology, description of which is as follows: 
 
1. Negative for intraepithelial lesion or 
malignancy (NIL)(showing organisms or other 
non-neoplastic changes e.g. Inflammation) 
2. Epithelial cell abnormalities 
 
A) Atypical squamous cells of undetermined 
significance (ASCUS) & Atypical Glandular 
cells of undetermined significance (AGUS). 
B) Low grade intra-epithelial lesion (LSIL) 
C) High grade intra-epithelial lesion (HSIL) 
D) Cervical  Carcinoma  (Squamous  cell  
carcinoma  & Adenocarcinoma) 
 
Data was analyzed by using Statistical Packages for 
Social Sciences (SPSS) version 23. Frequencies were 
calculated and cross tabulations were made using the 
descriptive statistics. 
Results: 
A total of 121 Lab reports were included in the study. 
Reasons of referral along with their frequencies are 
given in Table I. 
Lab reports of the Pap smear were reviewed that 
revealed the results tabulated in Table II. 
Patients were divided into two age groups i.e. less 
than 40 and greater than 40. Among them 59.5 %( 
n=72) were less than 40 years and 40.5 %( n=49) were 
greater than 40 years of age. On developing the 
relation between the two age groups and abnormal 
cervical cytologist in potentially pre-invasive forms, 66 
%( n=06) of them were picked up in women greater 
than 40 years of age group (p=0.203). 
 
Table I: Reasons of Referral 
Reason of Referral Frequency 
(n=121) 
Percentage 
PV Discharge 57 47.1 
Post-Menopausal 
Bleeding 
10 8.3 
Lower Abdominal Pain 11 9.1 
Intermittent Bleeding 21 17.4 
Post Coital Bleeding 11 9.1 
Dyspareunia 2 1.7 
Hypertrophied Cervix 1 0.8 
Oligomenorrhea 3 2.5 
Menorrhagia 5 4.1 
   
 
 
Table II Frequency of Lab Findings of Pap smear 
Laboratory Findings Frequency 
(n=121 
Percentage 
1. Normal 69 57 
2. Negative For 
Intraepithelial 
Lesion 
  
 -Inflammation 
Without Atypia. 
42 34.7 
3. Abnormal 
Cervical 
  
 Epithelium 
(Preinvasive) 
  
 -Inflammation 
With Atypia 
2 1.7 
 -Ascus* 3 2.5 
 -Lsil** 2 1.7 
 -Hisl*** 2 1.7 
4. Invasive Cervical 
Cancer 
1 0.8 
*Atypical squamous cells of undetermined significance. 
**Low grade squamous intraepithelial lesion. 
***High grade squamous intraepithelial lesion. 
 
Discussion: 
This study was conducted in order to determine the 
frequency of abnormal cervical cytologies in 
potentially pre-invasive forms by using Pap smear. 
Current study picked up 8.4% of the abnormal cervical 
cytologies including 0.8% of invasive cervical cancer 
as compared to a local study conducted in Swat with 
the result of 3.76 %( 8). An international study 
conducted in Saudi Arabia showed 9.2% of abnormal 
cervical cytologies that is in coherence with the current 
study (9). Another study from India was concluded 
with 3.6% of the results (10). 
There is literal evidence of the fact that most of the 
cervical epithelial abnormalities are asymptomatic 
unless they progress to the full blown form of cervical 
cancer. This progression takes a period of 10-15 years. 
Though current study was conducted on those 
patients who presented with some symptoms and 
picked up a total of 8.4% of abnormal cervical 
cytologies, there are big numbers of cases of abnormal 
cervical epithelia that go unnoticed. Multiple reasons 
address this issue, including their asymptomatic 
pattern, no proper screening system in Pakistan and 
lack of knowledge among women and health care 
providers regarding the importance of screening. 
First and foremost recommendation for the above 
mentioned issue is that the cervical cancer screening 
should be one of the governments funded screening 
programmes. Moreover, this programme should be 
designed on WHO’s recommended pattern i.e. 3 
yearly pap smear screening test followed by HPV 
testing in the age group of 21-29yrears and 5 yearly 
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pap smear screening test combined with HPV testing 
in the age group of 30-65 years. Secondly, women and 
health care providers should be equipped with the 
knowledge about the importance of screening via print 
media, electronic media, seminars and CME 
workshops. 
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